These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 318920)

  • 41. Modifying factors in urinary bladder carcinogenesis.
    Ito N; Fukushima S; Shirai T; Nakanishi K; Hasegawa R; Imaida K
    Environ Health Perspect; 1983 Mar; 49():217-22. PubMed ID: 6832095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutagenicities of N-nitrosamines on Salmonella.
    Yahagi T; Nagao M; Seino Y; Matsushima T; Sugimura T
    Mutat Res; 1977 Apr; 48(2):121-9. PubMed ID: 406555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Structure and metabolic fate of N-nitrosodialkylamines in relation to their organotropic carcinogenicity with special reference to induction of urinary bladder tumors].
    Mochizuki M; Suzuki E; Okada M
    Yakugaku Zasshi; 1997 Nov; 117(10-11):884-94. PubMed ID: 9414598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    McCormick DL; Ronan SS; Becci PJ; Moon RC
    Carcinogenesis; 1981; 2(3):251-4. PubMed ID: 7273310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of change in the levels of liver and kidney cytochrome P-450 isozymes in p53+/- knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Mori Y; Koide A; Fuwa K; Wanibuchi H; Fukushima S
    Mutagenesis; 2001 Sep; 16(5):377-83. PubMed ID: 11507236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic fate of N,N-dibutylnitrosamine in the rat.
    Suzuki E; Okada M
    Gan; 1980 Dec; 71(6):863-70. PubMed ID: 7274631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of repair synthesis of DNA in primary cultures of rat urothelial cells by derivatives of the bladder carcinogen, N-n-butyl-N-(4-hydroxybutyl)nitrosamine.
    Wang CY; Zukowski K; Daniel DS; Irving CC
    Chem Biol Interact; 1985; 53(1-2):99-105. PubMed ID: 3995657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro metabolism of bladder carcinogenic nitrosamines by rat liver and urothelial cells.
    Airoldi L; Magagnotti C; De Gregorio G; Moret M; Fanelli R
    Chem Biol Interact; 1992 Apr; 82(2):231-40. PubMed ID: 1568272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens.
    Rumruen K; Pool BL
    Mutat Res; 1984; 140(2-3):147-53. PubMed ID: 6379440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of disulfiram on the metabolism of the urinary bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
    Irving CC; Daniel DS
    Carcinogenesis; 1987 Sep; 8(9):1309-15. PubMed ID: 3113755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Damage and repair of DNA in urinary bladder epithelium of rats treated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Tsuda H; Miyata Y; Hagiwara A; Hasegawa R; Shirai T; Ito N
    Gan; 1977 Dec; 68(6):781-3. PubMed ID: 598647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic fate of N, N-dipropylnitrosamine and N, N-diamylnitrosamine in the rat, in relation to their lack of carcinogenic effect on the urinary bladder.
    Suzuki E; Okada M
    Gan; 1981 Aug; 72(4):552-61. PubMed ID: 7308667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutagenicity of the non-carcinogenic dibenzylnitrosamine and an alpha-acetoxy derivative.
    Jacobson MK; Barton RA; Yoder SS; Sigh S; Lyle RE
    Cancer Lett; 1979 Feb; 6(2):83-7. PubMed ID: 35280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mutagenicity of dialkyl nitrosamines in the Salmonella plate assay.
    Prival MJ; King VD; Sheldon AT
    Environ Mutagen; 1979; 1(2):95-104. PubMed ID: 399908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutagenicity of five cyclic N-nitrosamines: assay with Salmonella typhimurium.
    Stoltz DR; Sen NP
    J Natl Cancer Inst; 1977 Feb; 58(2):393-4. PubMed ID: 319245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of partial cystectomy on the induction of pre-neoplastic lesions in rat bladder initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by bladder carcinogens and promoters.
    Fukushima S; Hirose M; Okuda M; Nakanowatari J; Hatano A; Ito N
    Urol Res; 1982; 10(3):115-8. PubMed ID: 7135697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of protease inhibitors in mice treated with the hepatocarcinogen, hexachlorocyclohexane (alpha-isomer) and the bladder carcinogen, N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Arai H; Shirai T; Hananouchi M; Hirose M; Murasaki G; Ito N
    Gan; 1978 Aug; 69(4):593-5. PubMed ID: 81788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.
    Lijinsky W; Andrews AW
    Mutat Res; 1983 Oct; 111(2):135-44. PubMed ID: 6355832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of leupeptin, a protease inhibitor, on induction of bladder tumors in rats by n-butyl-n-(4-hydroxybutyl)nitrosamine.
    Kakizoe T; Takayasu H; Kawachi T; Sugimura T; Takeuchi T
    J Natl Cancer Inst; 1976 Feb; 56(2):433-5. PubMed ID: 1255776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experimental study on cystitis as a risk factor in urinary bladder carcinoma--effect of inflammation on N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)-induced rat urinary bladder carcinogenesis].
    Honda M
    Nihon Eiseigaku Zasshi; 1986 Dec; 41(5):851-62. PubMed ID: 3573398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.